D. Khayat

633 total citations
28 papers, 430 citations indexed

About

D. Khayat is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Khayat has authored 28 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Khayat's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (4 papers) and Estrogen and related hormone effects (3 papers). D. Khayat is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (4 papers) and Estrogen and related hormone effects (3 papers). D. Khayat collaborates with scholars based in France, Italy and United States. D. Khayat's co-authors include Gilles Sarfati, S. Zaïm, J J Duron, J Grellet, Marie‐France Bellin, G Auclerc, M Weil, E Antoine, Claude Soubrane and A. Benhammouda and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

D. Khayat

23 papers receiving 408 citations

Peers

D. Khayat
Gary B. Stillwagon United States
N J Meropol United States
Robert A. Rostock United States
Kenneth Pennington United States
M. Marcy France
Praveen Sridhar United States
Yu Ohkubo Japan
Minsig Choi United States
D. Khayat
Citations per year, relative to D. Khayat D. Khayat (= 1×) peers Lennart Bergqvist

Countries citing papers authored by D. Khayat

Since Specialization
Citations

This map shows the geographic impact of D. Khayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Khayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Khayat more than expected).

Fields of papers citing papers by D. Khayat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Khayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Khayat. The network helps show where D. Khayat may publish in the future.

Co-authorship network of co-authors of D. Khayat

This figure shows the co-authorship network connecting the top 25 collaborators of D. Khayat. A scholar is included among the top collaborators of D. Khayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Khayat. D. Khayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tolédano, A., et al.. (2015). 1968 Routine practice use of Oncotype Dx assay in French breast cancer patients. European Journal of Cancer. 51. S323–S323. 1 indexed citations
2.
Tempero, Margaret A., Jordan Berlin, Michel Ducreux, et al.. (2011). Pancreatic cancer treatment and research: an international expert panel discussion. Annals of Oncology. 22(7). 1500–1506. 47 indexed citations
3.
Sullivan, Richard, Jeffrey Peppercorn, Karol Sikora, et al.. (2011). Delivering Affordable Cancer Care in High-income Countries: a Lancet Oncology Commission. European Journal of Cancer. 47. 6–6. 5 indexed citations
4.
Penault–Llorca, F, et al.. (2005). Incidence and implications of HER2 and hormonal receptor overexpression in newly diagnosed metastatic breast cancer (MBC). Journal of Clinical Oncology. 23(16_suppl). 764–764. 15 indexed citations
5.
Spano, Jean‐Philippe, Sophie Taillibert, D. Khayat, & Philippe Terrier. (2001). Hibernoma, an uncommon tumor as a differential diagnosis of liposarcoma of the thigh.. PubMed. 20(6C). 4803–4. 2 indexed citations
6.
Buthiau, D., Éric-Charles Antoine, B. Wechsler, et al.. (1999). Imagerie clinique des métastases ostéocondensantes. La Revue de Médecine Interne. 20(4). 353–364.
7.
Séroussi, Brigitte, et al.. (1998). Hypertextual navigation operationalizing generic clinical practice guidelines for patient-specific therapeutic decisions.. PubMed. 488–92. 16 indexed citations
8.
Spaëth, D., et al.. (1997). Phase II studies of two trial regimens of topotecan as second-line single agent therapy in advanced breast cancer. European Journal of Cancer. 33. S158–S158. 5 indexed citations
9.
Bengtsson, Nils‐Olof, C Focan, A. Gudgeon, et al.. (1997). A phase III trial comparing vorozole (RIVIZOR™) versus aminoglutethimlde in the treatment of advanced postmenopausal breast cancer. European Journal of Cancer. 33. S148–S148. 10 indexed citations
10.
Antoine, Éric-Charles & D. Khayat. (1996). Dose intensification and breast cancer: Current results and future perspectives. Annals of Oncology. 7. 31–40. 4 indexed citations
11.
Laccourreye, O., Daniel Brasnu, V. Bassot, et al.. (1996). Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.. Journal of Clinical Oncology. 14(8). 2331–2336. 38 indexed citations
12.
Mouawad, Roger, A. Benhammouda, Olivier Rixe, et al.. (1996). Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden.. PubMed. 2(8). 1405–9. 61 indexed citations
13.
Buthiau, D., et al.. (1996). [Endometrial cancer: progress in the evaluation of locoregional extension by imaging techniques].. PubMed. 24(10). 757–61. 1 indexed citations
14.
Rixe, Olivier, E. Vuillemin, A. Benhammouda, et al.. (1995). A Phase II Study of Tamoxifen Combined with Cisplatin-Interleukin 2 and Alpha-Interferon in Metastatic Melanoma. American Journal of Clinical Oncology. 18(5). 421–424. 6 indexed citations
15.
Buthiau, D., et al.. (1995). [Breast cancer: role of MRI in follow-up of cases treated].. PubMed. 179(3). 693–705; discussion 705.
16.
Bellin, Marie‐France, S. Zaïm, Gilles Sarfati, et al.. (1994). Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.. Radiology. 193(3). 657–663. 123 indexed citations
17.
Soubrane, C., D. Khayat, Laurence Leenhardt, et al.. (1994). [Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].. PubMed. 23(4). 159–63. 2 indexed citations
18.
Auclerc, G, et al.. (1992). [Primary chemotherapy in the treatment of breast cancer].. PubMed. 37(6). 663–9. 17 indexed citations
19.
Jacquillat, C, Michael M. Weil, G Auclerc, et al.. (1991). [Tumor regression as a prognostic factor in breast cancer].. PubMed. 78(5). 435–43. 2 indexed citations
20.
Jacquillat, C, D. Khayat, M Weil, et al.. (1984). Non-Hodgkin's lymphoma occurring after hodgkin's disease four new cases and a review of the literature. Cancer. 53(3). 459–462. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026